Halefoglu Ahmet Mesrur, Bodelschwingh Bade Von, Altuntas Yuksel, Memis Bahar
Department of Radiology, University of Health Sciences Türkiye, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Türkiye.
Department of Endocrinology, University of Health Sciences Türkiye, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Türkiye.
Sisli Etfal Hastan Tip Bul. 2024 Apr 5;58(1):30-44. doi: 10.14744/SEMB.2023.02328. eCollection 2024.
The purpose of our study was to investigate the role of different magnetic resonance imaging (MRI) parameters in the characterization of adrenal masses.
A total of 150 patients who presented with 186 adrenal tumors were retrospectively evaluated in this study. Final patient cohort consisted of 17 pheochromocytomas, 3 adrenocortical carcinomas, 24 metastases, 31 lipid-poor adenomas and 111 lipid-rich adenomas. We carried out a visual assessment on FSE (Fast spin echo)T2 weighted images and also calculated T2 signal intensity ratio of all adrenal masses and also performed a qualitative assessment on chemical shift imaging (CSI) together with quantitative calculation using Adrenal to spleen signal intensity (si) ratio and Adrenal si index formulas. On dynamic contrast-enhanced sequences, visual assessment based on enhancement patterns on late-arterial phase images was performed and also mean signal intensity measurements were carried out. All examinations were interpreted by two abdominal radiologists in consensus who were blinded to the clinical and pathological findings. Statistical analysis was performed.
On FSE T2 weighted imaging, isointense to liver and slightly hyperintense than liver was found higher in benign cases, however, in malignant cases moderately and strikingly hyperintense than liver was higher than in benign cases (p=0.001, p<0.01). There was a statistically significant difference between the T2 signal intensity ratio values of adrenal tumor groups (p=0.001, p<0.01). In lipid-rich and lipid-poor adenoma groups, T2 signal intensity ratio values was significantly lower than in pheochromocytoma and metastasis cases. In malignant group, T2 signal intensity ratio values were found statistically significantly higher than in the benign group (p=0.001, p<0.01). There was a statistically significant difference between CSI visual assessment of adrenal tumor groups (p=0.001, p<0.01). Although moderate and significant signal intensity loss was usually detected in lipid-rich adenoma group, never detected in other tumor groups. There was also a statistically significant difference between benign and malignant adrenal tumor groups (p=0.001, p<0.01). In the malignant group, Adrenal to spleen si ratio values were found significantly higher whereas, Adrenal si index values were significantly lower compared to benign tumors (p=0.001, p<0.01). Based on malignancy, there was a statistically significant difference between adrenal tumor groups (p=0.001, p<0.01). Although capillary blush and homogenous type enhancement were more common in benign cases than in malignant ones, peripheral-patchy and strikingly capillary blush type enhancement was more frequent in malignant tumors. Based on malignancy, mean arterial signal intensity values of malignant tumors were statistically higher than benign tumors (p=0.001; p<0.01).
Dynamic contrast-enhanced MRI protocol including CSI aids in the characterization of indeterminate adrenal masses. Herein, the combined use of qualitative and quantitative parameters enables more tumors to be recognized that otherwise would be indeterminate.
本研究旨在探讨不同磁共振成像(MRI)参数在肾上腺肿块特征描述中的作用。
本研究对150例患有186个肾上腺肿瘤的患者进行了回顾性评估。最终患者队列包括17例嗜铬细胞瘤、3例肾上腺皮质癌、24例转移瘤、31例低脂腺瘤和111例富含脂质腺瘤。我们对快速自旋回波(FSE)T2加权图像进行了视觉评估,计算了所有肾上腺肿块的T2信号强度比,并对化学位移成像(CSI)进行了定性评估,同时使用肾上腺与脾脏信号强度(si)比和肾上腺si指数公式进行了定量计算。在动态对比增强序列上,根据延迟动脉期图像上的强化模式进行视觉评估,并进行平均信号强度测量。所有检查均由两位腹部放射科医生在不知情的情况下达成共识进行解读,他们对临床和病理结果均不知情。进行了统计分析。
在FSE T2加权成像中,与肝脏等信号且略高于肝脏信号的情况在良性病例中更为常见,然而,在恶性病例中,高于肝脏信号且呈中度和显著高信号的情况比良性病例更为常见(p = 0.001,p < 0.01)。肾上腺肿瘤组的T2信号强度比值之间存在统计学显著差异(p = 0.001,p < 0.01)。在富含脂质和低脂腺瘤组中,T2信号强度比值显著低于嗜铬细胞瘤和转移瘤病例。在恶性组中,T2信号强度比值在统计学上显著高于良性组(p = 0.001,p < 0.01)。肾上腺肿瘤组的CSI视觉评估之间存在统计学显著差异(p = 0.001,p < 0.01)。虽然在富含脂质腺瘤组中通常检测到中度和显著的信号强度降低,但在其他肿瘤组中从未检测到。良性和恶性肾上腺肿瘤组之间也存在统计学显著差异(p = 0.001,p < 0.01)。在恶性组中,与良性肿瘤相比,肾上腺与脾脏的si比值显著更高,而肾上腺si指数值显著更低(p = 0.001,p < 0.01)。基于恶性程度,肾上腺肿瘤组之间存在统计学显著差异(p = 0.001,p < 0.01)。虽然毛细血管强化和均匀型强化在良性病例中比恶性病例更常见,但外周斑片状和显著的毛细血管强化型在恶性肿瘤中更频繁。基于恶性程度,恶性肿瘤的平均动脉信号强度值在统计学上高于良性肿瘤(p = 0.001;p < 0.01)。
包括CSI的动态对比增强MRI方案有助于对不确定的肾上腺肿块进行特征描述。在此,定性和定量参数的联合使用能够识别更多原本不确定的肿瘤。